reviewTop 1% cited
EGFR and cancer prognosis
European Journal of Cancer · 2001 · Vol. 37 · pp. 9–15
Robert I. Nicholson✉(Cardiff University)Julia M.W. Gee(Cardiff University)M. E. Harper(Tenovus Cancer Care)
HER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsColorectal Cancer Treatments and StudiesMedicineEpidermal growth factor receptorOncologyInternal medicineLung cancerCancerBladder cancerEpidermal growth factorReceptor
MeSH terms
HumansLigandsNeoplasm ProteinsNeoplasmsPrognosisRetrospective StudiesBiomarkers, TumorReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesErbB Receptors
Citations
2,135
FWCI
20.29
field-weighted impact
References
45
Percentile
100%
vs. same field & year
Citations per year
Cited by
Surface Plasmon Resonance Scattering and Absorption of anti-EGFR Antibody Conjugated Gold Nanoparticles in Cancer Diagnostics: Applications in Oral Cancer
Nano Letters · 2005 · 1,899 citations
Active targeting schemes for nanoparticle systems in cancer therapeutics
Advanced Drug Delivery Reviews · 2008 · 1,702 citations
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Frontiers in Pharmacology · 2018 · 869 citations
Epidermal growth factor receptor mutations in lung cancer
Nature reviews. Cancer · 2007 · 3,115 citations
Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
Frontiers in Oncology · 2013 · 303 citations
The ErbB receptors and their role in cancer progression
Experimental Cell Research · 2003 · 611 citations
References
Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research
Breast Cancer Research and Treatment · 1995 · 367 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.